Featured Research

from universities, journals, and other organizations

Combination Therapy In HIV+ Children

Date:
June 6, 1997
Source:
Johns Hopkins Children's Center
Summary:
A combination of stavudine (d4t), didanosine (ddI), and indinavir was well-tolerated in HIV-positive children and showed powerful anti-viral effects, according to research out of the Baylor College of Medicine.

A combination therapy of stavudine (d4T), didanosine (ddI) and indinavir was well-tolerated in a study of HIV-infected children.

The study, conducted by Dr. Mark Kline, associate professor of pediatrics at Baylor College of Medicine in Houston, demonstrated that the drug combination was safe in a small group of symptomatic children.

"No child required either a dose reduction or interruption of therapy," said Kline. "In addition, there were marked changes in CD4 lymphocyte counts and blood HIV RNA concentrations, which suggests that there is potent antiviral activity."

The study evaluated the pharmacokinetics, tolerance, safety, immunologic effects, and antiviral activity of the combination therapy in 12 children, ages 4 to 13.

The children were assessed every four weeks for a period of 24 weeks.

All of the children had been treated previously with nucleoside antiretroviral agents including AZT, ddI and/or d4T.

"There was no obvious adverse interaction between d4T, ddI and indinavir when given in combination," Kline said. "Combination therapy produced impressive decreases in virus load in the body, and CD4 lymphocyte counts increased dramatically, suggesting improvement in the health of the patients' immune systems."

In addition, Kline found substantial amounts of indinavir in cerebrospinal fluid and an absence of HIV RNA, indicating there were antiviral effects within the central nervous system. Many HIV-infected children experience neurologic and developmental problems as a result of HIV's effects on the central nervous system. The research was presented last month at the the annual meeting of the Pediatric Academic Societies in Washington, DC.


Story Source:

The above story is based on materials provided by Johns Hopkins Children's Center. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Children's Center. "Combination Therapy In HIV+ Children." ScienceDaily. ScienceDaily, 6 June 1997. <www.sciencedaily.com/releases/1997/06/970606120339.htm>.
Johns Hopkins Children's Center. (1997, June 6). Combination Therapy In HIV+ Children. ScienceDaily. Retrieved April 24, 2014 from www.sciencedaily.com/releases/1997/06/970606120339.htm
Johns Hopkins Children's Center. "Combination Therapy In HIV+ Children." ScienceDaily. www.sciencedaily.com/releases/1997/06/970606120339.htm (accessed April 24, 2014).

Share This



More Health & Medicine News

Thursday, April 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Fungus Killing Bats, Spreading in US

Deadly Fungus Killing Bats, Spreading in US

AP (Apr. 24, 2014) A disease that has killed more than six million cave-dwelling bats in the United States is on the move and wildlife biologists are worried. White Nose Syndrome, discovered in New York in 2006, has now spread to 25 states. (April 24) Video provided by AP
Powered by NewsLook.com
Companies Ramp Up Wellness to Lower Health Costs

Companies Ramp Up Wellness to Lower Health Costs

AP (Apr. 24, 2014) That little voice telling you to exercise, get in shape and get healthy is probably coming from your boss. More companies are beefing up wellness programs to try and cut down their health care costs. (April 24) Video provided by AP
Powered by NewsLook.com
FDA Wants To Ban Sales Of E-Cigarettes To Minors

FDA Wants To Ban Sales Of E-Cigarettes To Minors

Newsy (Apr. 24, 2014) The Food and Drug Administration wants to crack down on the use of e-cigarettes, banning the sale of the product to minors. Video provided by Newsy
Powered by NewsLook.com
Michigan Man Sees Thanks to 'bionic Eye'

Michigan Man Sees Thanks to 'bionic Eye'

AP (Apr. 23, 2014) A legally blind Michigan man is 'seeing something new every day' thanks to a high-tech retinal implant procedure. He's one of the first in the country to receive a 'bionic eye' since the federal government approved the surgery. (April 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins